US Patent 7786136 Indazole-carboxamide compounds
Patent 7786136 was granted and assigned to Theravance on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+341 characters)
Article
Patent abstract
The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Adam A Goldblum0
Daniel D Long0
Daniel Marquess0
Paul Fatheree0
Roland Gendron0
S. Derek Turner0
Seok-Ki Choi0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07786136 Indazole-carboxamide compounds US Patent 7786136 Indazole-carboxamide compounds
Infobox
Patent Number
077861360
Patent Number
77861360
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077861360
Date of Patent
August 31, 2010
0Patent Application Number
120088400
Date Filed
January 15, 2008
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07786136 Indazole-carboxamide compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07786136
Date of patent
August 31, 2010
Patent application number
12008840
Date Filed
January 15, 2008
Patent primary examiner
Find more entities like US Patent 7786136 Indazole-carboxamide compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
